Enter your keywords

Search results

1. Dr Stephen McLaughlin

   ... Hsp90 directed anti-tumour drugs in development and clinical trials. ...

2. Dr Simon Pacey

   ... development, my research interests are: Early phase clinical trials (phase I/II) and Urological malignancy (prostate cancers). My projects ... proportion of investigator-led, locally sponsored clinical trials. Examples of open clinical trials include: Do Changes in ctDNA ...

3. Mr Samuel White

   ... actionable genomic results for patients enrolled on clinical trials and clinical studies led by researchers across the Centre.  CMDL ...

4. Dr Sujath Abbas

   ... DNA, envisioning its implementation in large scale clinical trials/screening. I have a Masters and a Bachelor’s degree in Biochemistry ...

5. Professor Tony Kouzarides

   ... MLL-leukaemia. This I-BET compound is currently in clinical trials. Tony is part of the Executive Board of the Cambridge Cancer Centre ...

6. Professor Vincent Gnanapragasam

   ... and completed numerous investigator led multicentre clinical trials including;  Predict Prostate RCT ,  PRIM biomarker ... studies). In recent years he has developed a new clinical trials programme exploring the concept of therapeutic intervention to slow or ...

7. Dr Will Ince

   ... All phase industry and investigator initiated clinical trials in renal, prostate and recurrent/metastatic head and neck cancer with ...

8. Dr Ali Amin Al Olama

   My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

9. Mr Arqum Anwar

   Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

10. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

11. Dr Alvis Brazma

    High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.

12. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

13. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...

14. Dr Annalise Katz-Summercorn

    Early detection in oesophageal adenocarcinoma

15. Dr Catherine Lindon

    My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...

16. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our approach is to identify key unknowns...

17. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...

Pages